Cite

    Burggraaf, B. et al. (2020). A placebo‐controlled proof‐of‐concept study of alirocumab on postprandial lipids and vascular elasticity in insulin‐treated patients with type 2 diabetes mellitus. Diabetes, obesity & metabolism. 22 (5), pp. 807-816. [Online].